Cargando…
Immunometabolic bases of type 2 diabetes in the severity of COVID-19
The outbreak of coronavirus disease 2019 (COVID-19) is caused by the novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). COVID-19 and type 2 diabetes (T2D) have now merged into an ongoing global syndemic that is threatening the lives of millions of people around the globe. For this r...
Autores principales: | Viurcos-Sanabria, Rebeca, Escobedo, Galileo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311488/ https://www.ncbi.nlm.nih.gov/pubmed/34326952 http://dx.doi.org/10.4239/wjd.v12.i7.1026 |
Ejemplares similares
-
Editorial: Immunometabolic mechanisms underlying the severity of COVID-19
por: Kzhyshkowska, Julia, et al.
Publicado: (2022) -
Editorial: Community series in immunometabolic mechanisms underlying the severity of COVID-19, volume II
por: Kzhyshkowska, Julia, et al.
Publicado: (2023) -
Role of the renin-angiotensin system in the development of COVID-19-associated neurological manifestations
por: Méndez-García, Lucía A., et al.
Publicado: (2022) -
In Vitro Exposure of Primary Human T Cells and Monocytes to Polyclonal Stimuli Reveals a Basal Susceptibility to Display an Impaired Cellular Immune Response and Develop Severe COVID-19
por: Viurcos-Sanabria, Rebeca, et al.
Publicado: (2022) -
Blood-brain Barrier Damage is Pivotal for SARS-CoV-2 Infection to the Central Nervous System
por: Rodríguez-Morales, Jahir, et al.
Publicado: (2022)